Andrew L. Pecora, Chief Medical Officer at NeoStem, Inc. (NBS), bought 50,000 shares at $0.59 ($30K) on 2011-12-14, disclosed to the SEC on 2011-12-15.
Open-market purchase of $30k NBS by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.59 | 40,000 | $24K | 79.7% |
| 2 | $0.60 | 10,000 | $6K | 20.3% |
| Total | $0.59 avg | 50,000 | $30K | 100% |
| Filing → |
| NBS | BUY | 2014-11-25 | $50K | — | Filing → |
| TLOG | BUY | 2014-11-19 | $91K | — | Filing → |
| TLOG | BUY | 2013-12-19 | $186K | — | Filing → |